e-learning
resources
Milan 2017
Sunday, 10.09.2017
"Alarming" immunological patterns in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping
I. Agache (Brasov/Brasov, Romania)
Source:
International Congress 2017 – "Alarming" immunological patterns in asthma
Session:
"Alarming" immunological patterns in asthma
Session type:
Poster Discussion
Number:
579
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Agache (Brasov/Brasov, Romania). Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping. 579
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Overview and history of different ways of assessing and monitoring inflammatory airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019
Year: 2020
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Searching for inflammatory and oxidative-stress markers capable of clustering severe asthma.
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD
Source: Eur Respir J 2013; 42: 891-892
Year: 2013
Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
The identification of asthma phenotypes by categorical PCA: Combinatorial analysis of clinical parameters and dysfunctional blood eosinophils
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Th-17 cytokine profile in a Greek asthmatic population. Correlation with asthma severity and biomarkers of inflammation.
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort
Source: Eur Respir J 2005; 26: Suppl. 49, 51s
Year: 2005
Asthma endotypes: a new approach to classification of disease entities within asthma
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013
Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label
Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017
Year: 2018
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006
Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes
Source: Eur Respir J 2015; 46: 688-696
Year: 2015
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept